AstraZeneca pulls breast cancer and endometriosis treatment from Australian market | ABC NEWS

A life-saving breast cancer and endometriosis drug will be pulled from Australian shelves by a major global drug manufacturer later this year.
Goserelin 3.6mg implant, also known as Zoladex, will be removed from both the Pharmaceutical Benefits Scheme (PBS) and the private market in November, at the request of manufacturer AstraZeneca, for what it says are commercial reasons.
Subscribe: http://ab.co/1svxLVE
Read more here: https://www.abc.net.au/news/2026-06-04/breast-cancer-endometriosis-drug-zoladex-discontinued/106726158

Note: In most cases, our captions are auto-generated.

#ABCNEWS #ABCNEWSAustralia #abcnewschannel